Shares of Janux Therapeutics surged after its prostate cancer treatment was selected for expansion trials following what it called encouraging efficacy and safety results.

When it comes to managing prostate cancer, there is no one-size-fits-all approach. Men must consider a variety of factors ...

A recent study reveals that immunosuppression, or reduced immune response, in prostate cancer is associated with a ...

The study of prostate cancer patients in the VA system found some with limited life expectancy were being treated with ...

Researchers have identified a new role for the enzyme EZH2 in promoting the progression of aggressive, treatment-resistant ...

An enzyme called EZH2 has an unexpected role in driving aggressive tumor growth in treatment-resistant prostate cancers, ...

Benign Prostatic Hyperplasia (BPH), or an enlarged prostate, is a common condition in aging men that can cause urinary ...

Menadione, a vitamin K precursor, shows promise in slowing prostate cancer in mice by disrupting cancer cell survival ...